Patent application title: Plants Producing 2N Gametes or Apomeiotic Gametes
Inventors:
IPC8 Class: AC12N1582FI
USPC Class:
1 1
Class name:
Publication date: 2021-06-03
Patent application number: 20210163972
Abstract:
The invention relates to plants wherein the protein OSD1, involved in the
transition from meiosis I to meiosis II is inactive. These plants produce
Second Division Restitution (SDR) 2n gametes. The invention further
relates to plants wherein the inactivation of OSD1 is combined with the
inactivation of a gene involved in meiotic recombination in plants, and
of a gene involved in the monopolar orientation of the kinetochores
during meiosis. These plants produce apomeiotic gametes. These plants are
useful in plant breeding.Claims:
1-13. (canceled)
14. A method for obtaining a plant producing Second Division Restitution 2n gametes, comprising inhibiting in said plant an Omission of Second Division 1 protein (OSD1), wherein said plant is maize, wherein said OSD1 protein allows a second meiotic division to occur, and thereby is necessary for the transition from meiosis I to meiosis II, and wherein the inhibition of the OSD1 protein is obtained by (i) mutating an OSD1 gene or its promoter and selecting a mutant plant having partially or totally lost OSD1 protein activity, or (ii) expressing a silencing RNA targeting the OSD1 gene encoding said OSD1 protein in said plant, and thereby obtaining a maize plant that forms dyads.
15. The method of claim 14, wherein said OSD1 protein has at least 50% sequence identity with the OSD1 protein of Oryza sativa as set forth in SEQ ID NO: 35.
16. The method of claim 14, wherein inhibition of the OSD1 protein is obtained by of mutating the OSD1 gene or of its promoter, and silencing a mutant plant having partially or totally lost the OSD1 protein activity.
17. The method of claim 14, wherein the inhibition of the OSD1 protein is obtained by expressing in said plant of a silencing RNA targeting the gene encoding said protein.
18. The method of claim 17, wherein expressing in said plant a silencing RNA comprises expression of a hairpin construct from an expression cassette comprising: a promoter functional in plant cell; at least one DNA construct selected among: a) one or more DNA construct(s) of 200 to 1000 bp, each comprising a fragment of a cDNA of OSD1 or its complement, or having at least 95% identity with said fragment, said DNA sequence(s) being placed under transcriptional control of said promoter, b) one or more hairpin DNA construct(s) capable, when transcribed, of forming a hairpin RNA targeting an OSD1 gene, or c) one or more DNA construct(s) capable, when transcribed, of forming a miRNA targeting an OSD1 gene said DNA construct(s) being placed under transcriptional control of said promoter.
19. The method of claim 17, wherein expressing in said plant a silencing RNA comprises expression of a hairpin construct from an expression cassette comprising: a promoter functional in plant cell; and at least one hairpin DNA construct(s) capable, when transcribed, of forming a hairpin RNA targeting an OSD1 gene, said DNA construct(s) being placed under transcriptional control of said promoter.
20. The method of claim 14, wherein inhibition of the OSD1 protein is obtained by mutagenesis of the OSD1 gene or its promoter to provide a plant mutant heterozygous for the mutation and self-fertilizing the mutant plant to obtain a mutant plant homozygous for the mutation.
21. A method for obtaining a plant producing apomeiotic gametes, wherein said plant is maize, wherein said method comprises an inhibition in said plant of the following native plant proteins: (a) an Omission of Second Division 1 protein (OSD1) and, (b) a plant protein involved in initiation of meiotic recombination in plants, said protein being selected among: (i) a plant sporulation 11-1 (SPO11-1) protein, wherein said protein has at least 40% sequence identity with the SPO11-1 protein of SEQ ID NO: 2; (ii) a plant sporulation 11-2 (SPO11-2) protein, wherein said protein has at least 40% sequence identity with the SPO11-2 protein of SEQ ID NO: 3; (iii) a plant putative recombination initiation defect 1 (PRD1) protein, wherein said protein has at least 25% sequence identity with the PRD1 protein of SEQ ID NO: 4; or (iv) a plant homologous pairing aberration in rice 1 (PAIR1) protein, wherein said protein has at least 30% sequence identity with the PAIR1 protein of SEQ ID NO: 5; and (c) a plant meiotic recombination protein 8 (Rec8), wherein said protein has at least 40% sequence identity with the Rec8 protein of SEQ ID NO: 6, wherein the inhibition of at least one of the OSD1, SPO11-1, SPO11-2, PRD1, PAIR1, or Rec8 proteins is obtained by: (i) mutating the gene encoding said protein or its promoter and selecting a mutant plant having partially or totally lost an activity of said protein, or (ii) expressing in said plant a silencing RNA targeting the gene encoding said protein.
22. The method of claim 8, wherein said OSD1 protein has at least 50% sequence identity with the OSD1 protein of Oryza sativa as set forth in SEQ ID NO: 35.
23. The method of claim 21, wherein inhibition of at least one of the OSD1, SPO11-1, SPO11-2, PRD1, PAIR1, or Rec8 proteins is obtained by mutating the gene encoding said protein of or of its promoter, and selecting mutants having partially or totally lost the activity of said protein.
24. The method of claim 21, wherein inhibition of at least one of the OSD1, SPO11-1, SPO11-2, PRD1, PAIR1, or Rec8 proteins is obtained by expressing a silencing RNA targeting the gene encoding said protein in said plant.
25. The method of claim 21 comprising the steps of: (a) providing a plant having a mutation within an allele of the OSD1 gene resulting in the inhibition of the protein encoded by this allele, said plant being heterozygous for this mutation; (b) providing a plant having a mutation within an allele of a gene selected from the SPO11-1, SPO11-2, PRD1, PAIR1 gene resulting in the inhibition of the protein encoded by said allele, said plant being heterozygous for this mutation; (c) providing a plant having a mutation within an allele of the REC8 gene resulting in the inhibition of the protein encoded by said allele, said plant being heterozygous for this mutation; and (d) crossing the plants of steps a) b) and c) in order to obtain a plant having a mutation within an allele of the OSD1 gene, a mutation within an allele of a gene selected from the SPO11-1, SPO11-2, PRD1, PAIR1 gene, and a mutation within an allele of the REC8 gene, said plant being heterozygous for each mutation; (e) self-fertilizing the plant of step d) in order to obtain a plant homozygous for the mutation within the OSD1 gene, for the mutation within an allele of a gene selected from the SPO11-1, SPO11-2, PRD1, PAIR1 gene, and for the mutation within an allele of the REC8 gene.
26. A method for producing Second Division Restitution 2n gametes, wherein said method comprises cultivating a plant obtained by the method of claim 14, and recovering the gametes produced by said plant.
27. The method for producing apomeiotic gametes, wherein said method comprises cultivating a plant obtained by the method of claim 21, and recovering the gametes produced by said plant.
Description:
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation of U.S. application Ser. No. 15/006,847, filed Jan. 26, 2016, which is a continuation of U.S. application Ser. No. 13/143,530, filed Sep. 16, 2011, which in turn is a U.S. National Stage application of international application PCT/IB2010/000184, filed in English on Jan. 6, 2010, which designates the United States, and which claims priority to EP 09290010.9, filed in English on Jan. 7, 2009. Each of these applications is incorporated by reference herein in its entirety.
SEQUENCE LISTING SUBMISSION VIA EFS-WEB
[0002] A computer readable text file, entitled "SequenceListing.txt" created on Dec. 9, 2020, with a file size of 36 kb contains the sequence listing for this application and is hereby incorporated by reference in its entirety.
BACKGROUND
[0003] The invention relates to plants that produce 2n Second Division Restitution (SDR) gametes, and to plants that produce apomeiotic gametes, and to their use in plant breeding.
[0004] 2n gametes (also known as diplogametes) are gametes having the somatic chromosome number rather than the gametophytic chromosome number. They have been shown to be useful for the genetic improvement of several crops (for review, cf. for instance RAMANNA & JACOBSEN, Euphytica 133, 3-18, 2003). In particular, the production of diplogametes allow crosses between plants of different ploidy level, for instance crosses between tetraploid crop plants and their diploid wild relatives, in order to use their genetic diversity in plant breeding programs.
[0005] The formation of 2n gametes results from anomalies during meiosis (for review cf. VEILLEUX, Plant Breeding Reviews 3, 252-288, 1985, or BRETAGNOLLE & THOMPSON, New Phytologist 129, 1-22, 1995).
[0006] In normal meiosis, chromosomes first duplicate, resulting in pairs of sister chromatids. This round of replication is followed by two rounds of division, known as meiosis I and meiosis II. During meiosis I homologous chromosomes recombine and are separated into two cells, each of them comprising one entire haploid content of chromosomes. In meiosis II the two cells resulting from meiosis I further divide, and the sister chromatids segregate. The spores resulting from this division are thus haploid and carry recombined genetic information.
[0007] The abnormalities leading to 2n gametes formation include in particular abnormal cytokinesis, the skip of the first or second meiotic division, or abnormal spindle geometry (for review cf. VEILLEUX, Plant Breeding Reviews 3, 252-288, 1985, or BRETAGNOLLE & THOMPSON, New Phytologist 129, 1-22, 1995). These abnormalities lead to different classes of unreduced gametes. For instance, failure of the first meiotic division results in First Division Restitution (FDR) gametes, while failure of the second meiotic division results in Second Division Restitution (SDR) gametes.
[0008] Although numerous mutants able to produce 2n gametes have been reported in various plant species, only one gene implicated in the formation of 2n pollen has been identified and characterized at the molecular level until now. The inactivation of this gene, designated AtPS1 (for Arabidopsis thaliana parallel spindles), generates diploid male spores, giving rise to viable diploid pollen grains and to spontaneous triploid plants in the progeny. This gene and its use for producing 2n pollen are disclosed in European Patent application 08490672, filed on Jul. 8, 2008, and in the publication of D'ERFURTH et al (PLoS Genet. 2008 November; 4(11):e1000274. Epub 2008 Nov. 28).
SUMMARY
[0009] The inventors have now identified in the model plant Arabidopsis thaliana, another gene implicated in the formation of 2n gametes in plants. The inventors have found that inactivation of this gene results in the skipping of the second meiotic division. This generates diploid male and female spores, giving rise to viable diploid male and female gametes, which are SDR gametes. This gene will be hereinafter designated OSD1, for omission of second division. The sequence of the OSD1 gene of Arabidopsis thaliana is available in the TAIR database under the accession number At3g57860, or in the GenBank database under the accession number NM_115648. This gene encodes a protein of 243 aa (GenBank NP_191345), whose sequence is also represented in the enclosed sequence listing as SEQ ID NO: 1.
[0010] The OSD1 gene of Arabidopsis thaliana has been previously depicted as "UVI4-Like" gene (UVI4-L), in a publication of HASE et al. (Plant J, 46, 317-26, 2006), which describes its paralogue, named UVI4. According to HASE et al. UVI4 acts as a suppressor of endo-reduplication and is necessary for maintaining the mitotic state whereas OSD1 (UVI4-L) does not appear to be required for this process. In contrast, as shown herein, OSD1 appears necessary for allowing the transition from meiosis I to meiosis II.
[0011] The inventors have also identified in rice (Oryza sativa) an ortholog of the OSD1 gene of Arabidopsis thaliana. The sequence of the OSD1 gene of Oryza sativa is available in the OryGenes or TAIR databases under the accession number Os02g37850. It encodes a protein of 234 aa, whose sequence is represented in the enclosed sequence listing as SEQ ID NO: 35. The OSD1 proteins of Arabidopsis thaliana and Oryza sativa have 23.6% identity and 35% similarity over the whole length of their sequences.
[0012] The invention thus provides a method for obtaining a plant producing Second Division Restitution 2n gametes, wherein said method comprises the inhibition in said plant of a protein hereinafter designated as OSD1 protein, wherein said protein has at least 20%, and by order of increasing preference, at least 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 98% sequence identity, or at least 29%, and by order of increasing preference, at least 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 98% sequence similarity with the AtOSD1 protein of SEQ ID NO: 1 or with the OsOSD1 protein of SEQ ID NO: 35.
BRIEF DESCRIPTION OF THE DRAWINGS
[0013] FIG. 1 provides a schematic comparison between the mechanisms of mitosis, normal meiosis, meiosis in the osd1 mutant, meiosis in a mutant lacking SPO11-1 activity (Atspo11-1), meiosis in a double mutant lacking both SPO11-1 and REC8 activity (Atspo11-1/Atrec8), and meiosis in the MiMe mutant.
[0014] FIG. 2 shows the intron/exon structure of the OSD1 gene and the location of the two different Ds insertions.
[0015] FIG. 3 are images representing meiosis in wild-type plants. Panel A: Pachytene where homologous chromosomes are fully synapsed. Panel B: Diakinesis where five pairs of homologous chromosomes (bivalent), linked by chiasmata, are observed. Panel C: Metaphase I where the five bivalent are aligned on the metaphase plate. Panel D: Anaphase I where the homologous chromosomes are separated. Panel E: Telophase I. Panel F: Metaphase II where pairs of sister chromatids align on the metaphase plates. Panel G: Anaphase II where the sister chromatids are separated. Panels H and I: Telophase I where four haploid spores are formed (tetrad). The scale bar shown is 10 .mu.m.
[0016] FIG. 4 are images representing meiosis in osd1 mutants. Panels A and B show male meiotic products stained with toluidine blue. Panel A shows a wild type tetrad. Panel B shows a dyad in the osd1-1 mutant. Panels C and D show that male meiosis in osd1 is indistinguishable from wild type until telophase I (compared to FIG. 3, Panel E), but no figures characteristic of a second division were observed. Panel C: Pachytene. Panel D: Diakinesis. Panel E: metaphase I. Panel F: Anaphase I. Panel G: Telphase I. Panel H: Metaphase I of female meiosis in osd1.
[0017] FIG. 5 shows chromosome behavior during male and female meiosis of osd1/Atrec8/Atspo11-1 mutants. Panel A: Male metaphase I Panel B: Male anaphase I where the vignette (insert) shows a dyad in MiMe. Panel C: Female metaphase I. Panel D: Female anaphase I. The scale bar shown is 10 .mu.m.
[0018] FIG. 6 shows images illustrating that in MiMe plants, when meiosis is replaced by mitosis, ploidy is expected to double with each generation. Left column of images panels A, B and C: show mitotic metaphases, where scale bar=10 .mu.m. Right column of images D, E and F of images, respectively, are the corresponding four weeks old plants (where the scale bar=2 cm) and inserts show flowers (where the scale bar=1 mm).
[0019] FIG. 7 illustrates the production of 100% of dyads instead of tetrads as meiotic products in AMB12 mutants (n>400). Panel A shows the tetrad of spores in the wild type and Panel B shows the dyad of spores in AMB12.
DETAILED DESCRIPTION
[0020] Unless otherwise specified, the protein sequence identity and similarity values provided herein are calculated over the whole length of the sequences, using the BLASTP program under default parameters, or the Needleman-Wunsch global alignment algorithm (EMBOSS pairwise alignment Needle tool under default parameters). Similarity calculations are performed using the scoring matrix BLOSUM62.
[0021] The SDR 2n gametes produced according to the invention are useful in all the usual applications of 2n gametes, for instance for producing polyploids plants, or to allow crosses between plants of different ploidy level. They can also be useful in methods of genetic mapping, for instance the method of "Reverse progeny mapping" disclosed in US Patent Application 20080057583.
[0022] The inventors have further found that by combining the inactivation of OSD1, with the inactivation of two other genes, one (SPO11-1) which encodes a protein necessary for efficient meiotic recombination in plants, and whose inhibition eliminates recombination and pairing (GRELON et al., Embo J, 20, 589-600, 2001), and another (REC8, At2g47980) which encodes a protein necessary for the monopolar orientation of the kinetochores during meiosis (CHELYSHEVA et al., J Cell Sci, 118, 4621-32, 2005), and whose inhibition modifies chromatid segregation, resulted in a genotype in which meiosis is totally replaced by mitosis without affecting subsequent sexual processes. This genotype will be called hereinafter MiMe for "mitosis instead of meiosis". This replacement of meiosis by mitosis results in apomeiotic gametes, retaining all the parent's genetic information (BICKNELL & KOLTUNOW, Plant Cell, 16 Suppl, S228-45, 2004).
[0023] FIG. 1 provides a schematic comparison between the mechanisms of mitosis, normal meiosis, meiosis in the osd1 mutant, meiosis in a mutant lacking SPO11-1 activity (Atspo11-1), meiosis in a double mutant lacking both SPO11-1 and REC8 activity (Atspo11-1/Atrec8), and meiosis in the MiMe mutant.
[0024] During mitosis in diploid cells, chromosomes replicate and sister chromatids segregate to generate daughter cells that are diploid and genetically identical to the initial cell. During normal meiosis, two rounds of chromosome segregation follow a single round of replication. At division one, homologous chromosomes recombine and are separated. Meiosis II is more similar to mitosis resulting in equal distribution of sister chromatids. The obtained spores are thus haploid and carry recombined genetic information. In the osd1 mutant (this study) meiosis II is skipped giving rise to diploid spores and SDR gametes with recombined genetic information.
[0025] The Atspo11-1 mutant undergoes an unbalanced first division followed by a second division leading to unbalanced spores and sterility.
[0026] The Atspo11-1/Atrec8 double mutant undergoes a mitotic-like division instead of a normal first meiotic division, followed by an unbalanced second division leading to unbalanced spores and sterility.
[0027] In the triple osd1/Atspo11-1/Atrec8 mutant (MiMe), the presence of the Atspo11-1 and Atrec8 mutations leads to a mitotic-like first meiotic division and the presence of the osd1 mutation prevents the second meiotic division from occurring. Thus meiosis is replaced by a mitotic-like division. The obtained spores and gametes are genetically identical to the initial cell.
[0028] The apomeiotic gametes produced by the MiMe mutant can be used, in the same way as the SDR 2n gametes, for producing polyploids plants, or for crossing plants of different ploidy level. They are also of interest for the production of apomictic plants, i.e plants which are able to form seeds from the maternal tissues of the ovule, resulting in progeny that are genetic clones of the maternal parent. Although it exists in over 400 species of angiosperms, very few crop species are apomictic and attempts to introduce this trait by crossing have failed (SAVIDAN, The Flowering of Apomixis: From Mechanisms to Genetic Engineering 2001; SPILLANE et al., Sexual Plant Reproduction, 14, 2001).
[0029] A further object of the present invention is thus a method for obtaining a plant producing apomeiotic gametes, wherein said method comprises the inhibition in said plant of the following proteins:
[0030] a) an OSD1 protein as defined above;
[0031] b) a protein involved in initiation of meiotic recombination in plants, said protein being selected among:
[0032] i) a protein hereinafter designated as SPO11-1 protein, wherein said protein has at least 40%, and by order of increasing preference, at least 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 98% sequence identity, or at least 60%, and by order of increasing preference, at least, 65, 70, 75, 80, 85, 90, 95 or 98% sequence similarity with the SPO11-1 protein of SEQ ID NO: 2;
[0033] ii) a protein hereinafter designated as SPO11-2 protein, wherein said protein has at least 40%, and by order of increasing preference, at least 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 98% sequence identity, or at least 60%, and by order of increasing preference, at least, 65, 70, 75, 80, 85, 90, 95 or 98% sequence similarity with the SPO11-2 protein of SEQ ID NO: 3;
[0034] iii) a protein hereinafter designated as PRD1 protein, wherein said protein has at least 25%, and by order of increasing preference, at least 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 98% sequence identity, or at least 35%, and by order of increasing preference, at least, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 98% sequence similarity with the PRD1 protein of SEQ ID NO: 4;
[0035] iv) a protein hereinafter designated as PAIR1 protein, wherein said protein has at least 30%, and by order of increasing preference, at least 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 98% sequence identity, or at least 40%, and by order of increasing preference, at least, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 98% sequence similarity with the PAIR1 protein of SEQ ID NO: 5;
[0036] c) a protein hereinafter designated as Rec8 protein, wherein said protein has at least 40%, and by order of increasing preference, at least 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 98% sequence identity, or at least 45%, and by order of increasing preference, at least, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 98% sequence similarity with the Rec8 protein of SEQ ID NO: 6.
[0037] SEQ ID NO: 2 represents the sequence of the SPO11-1 protein of Arabidopsis thaliana. This sequence is also available in the Swissprot database under the accession number Q9M4A2.
[0038] SEQ ID NO: 3 represents the sequence of the SPO11-2 protein of Arabidopsis thaliana. This sequence is also available in the SwissProt database under the accession number Q9M4A1.
[0039] SEQ ID NO: 4 represents the sequence of the PRD1 protein of Arabidopsis thaliana. This sequence is also available in the GenBank database under the accession number ABQ12642.
[0040] SEQ ID NO: 5 represents the sequence of the PAIR1 protein of Arabidopsis thaliana. This sequence is also available in the GenBank database under the accession number NP_171675.
[0041] SEQ ID NO: 6 represents the sequence of the Rec8 protein of Arabidopsis thaliana. This sequence is also available in the GenBank database under the accession number NP_196168.
[0042] The SPO11-1, SPO11-2, PRD1, PAIR1, and Rec8 proteins are conserved in higher plants, monocotyledons as well as dicotyledons. By way of non-limitative examples of orthologs of SPO11-1, SPO11-2, PRD1, PAIR1 and Rec8 proteins of Arabidopsis thaliana in monocotyledonous plants, one can cite the Oryza sativa SPO11-1, SPO11-2, PRD1, PAIR1, and Rec8 proteins. The sequence of the Oryza sativa SPO11-1 protein is available in GenBank under the accession number AAP68363; the sequence of the Oryza sativa SPO11-2 protein is available in GenBank under the accession number NP_001061027; the sequence of the Oryza sativa PRD1 protein is available in GenBank under the accession number EAZ30311; the sequence of the Oryza sativa PAIR1 protein is available in SwissProt under the accession number Q75RY2; the sequence of the Oryza sativa Rec8 protein is available in GenBank under the accession number AAQ75095.
[0043] The inhibition of the above mentioned OSD1, SPO11-1, SPO11-2, PRD1, PAIR1, or Rec8 proteins can be obtained either by abolishing, blocking, or decreasing their function, or advantageously, by preventing or down-regulating the expression of the corresponding genes.
[0044] By way of example, inhibition of said protein can be obtained by mutagenesis of the corresponding gene or of its promoter, and selection of the mutants having partially or totally lost the activity of said protein. For instance, a mutation within the coding sequence can induce, depending on the nature of the mutation, the expression of an inactive protein, or of a protein with impaired activity; in the same way, a mutation within the promoter sequence can induce a lack of expression of said protein, or decrease thereof.
[0045] Mutagenesis can be performed for instance by targeted deletion of the coding sequence or of the promoter of the gene encoding said protein or of a portion thereof, or by targeted insertion of an exogenous sequence within said coding sequence or said promoter. It can also be performed by inducing random mutations, for instance through EMS mutagenesis or random insertional mutagenesis, followed by screening of the mutants within the desired gene. Methods for high throughput mutagenesis and screening are available in the art. By way of example, one can mention TILLING (Targeting Induced Local Lesions IN Genomes, described by McCallum et al., 2000).
[0046] Among the mutations within the OSD1 gene, those resulting in the ability to produce SDR 2n gametes can be identified on the basis of the phenotypic characteristics of the plants which are homozygous for this mutation: these plants can form at least 5%, preferably at least 10%, more preferably at least 20%, still more preferably at least 50%, and up to 100% of dyads as a product of meiosis.
[0047] Among the mutations within a gene encoding a protein involved in initiation of meiotic recombination in plants, such as the SPO11-1 gene or the SPO11-2, PRD1, or PAIR1 gene, those useful for obtaining a plant producing apomeiotic gametes can be identified on the basis of the phenotypic characteristics of the plants which are homozygous for this mutation, in particular the presence of univalents instead of bivalents at meiosis I, and the sterility of the plant.
[0048] Among the mutants having a mutation within the REC8 gene, those useful for obtaining a plant producing apomeiotic gametes can be identified on the basis of the phenotypic characteristics of the plants which are homozygous for this mutation, in particular chromosome fragmentation at meiosis, and sterility of the plant.
[0049] According to a preferred embodiment of the method of the invention for obtaining a plant able to produce SDR 2n gametes, said method comprises:
[0050] a) providing a plant having a mutation within an allele of the OSD1 gene resulting in the inhibition of the protein encoded by this allele, said plant being heterozygous for this mutation;
[0051] b) self fertilizing said plant of step a) in order to obtain a plant homozygous for said mutation.
[0052] According to a preferred embodiment of the method of the invention for obtaining a plant able to produce apomeiotic gametes, said method comprises:
[0053] a) providing a plant having a mutation within an allele of the OSD1 gene resulting in the inhibition of the protein encoded by this allele, said plant being heterozygous for this mutation;
[0054] b) providing a plant having a mutation within an allele of a gene selected among the SPO11-1, SPO11-2, PRD1, or PAIR1 gene resulting in the inhibition of the protein encoded by said allele, said plant being heterozygous for this mutation;
[0055] c) providing a plant having a mutation within an allele of the REC8 gene resulting in the inhibition of the protein encoded by said allele, said plant being heterozygous for this mutation;
[0056] e) crossing the plants of steps a) b) and c) in order to obtain a plant having a mutation within an allele of the OSD1 gene, a mutation within an allele of a gene selected among the SPO11-1, SPO11-2, PRD1, or PAIR1 gene, and a mutation within an allele of the REC8 gene, said plant being heterozygous for each mutation;
[0057] f) self fertilizing the plant of step e) in order to obtain a plant homozygous for the mutation within the OSD1 gene, for the mutation within the gene selected among the SPO11-1, SPO11-2, PRD1, or PAIR1 gene, and for the mutation within the REC8 gene.
[0058] Alternatively, the inhibition of the target protein is obtained by silencing of the corresponding gene. Methods for gene silencing in plants are known in themselves in the art. For instance, one can mention by antisense inhibition or co-suppression, as described by way of example in U.S. Pat. Nos. 5,190,065 and 5,283,323. It is also possible to use ribozymes targeting the mRNA of said protein.
[0059] Preferred methods are those wherein gene silencing is induced by means of RNA interference (RNAi), using a silencing RNA targeting the gene to be silenced. Various methods and DNA constructs for delivery of silencing RNAs are available in the art.
[0060] A "silencing RNA" is herein defined as a small RNA that can silence a target gene in a sequence-specific manner by base pairing to complementary mRNA molecules. Silencing RNAs include in particular small interfering RNAs (siRNAs) and microRNAs (miRNAs).
[0061] Initially, DNA constructs for delivering a silencing RNA in a plant included a fragment of 300 bp or more (generally 300-800 bp, although shorter sequences may sometime induce efficient silencing) of the cDNA of the target gene, under transcriptional control of a promoter active in said plant. Currently, the more widely used silencing RNA constructs are those that can produce hairpin RNA (hpRNA) transcripts. In these constructs, the fragment of the target gene is inversely repeated, with generally a spacer region between the repeats (for review, cf. WATSON et al., 2005). One can also use artificial microRNAs (amiRNAs) directed against the gene to be silenced (for review about the design and applications of silencing RNAs, including in particular amiRNAs, in plants cf. for instance OSSOWSKI et al., (Plant J., 53, 674-90, 2008).
[0062] The present invention provides tools for silencing one or more target gene(s) selected among OSD1, SPO11-1, SPO11-2, PRD1, PAIR1, and REC8, including in particular expression cassettes for hpRNA or amiRNA targeting said gene (s).
[0063] An expression cassette of the invention may comprise for instance:
[0064] a promoter functional in a plant cell;
[0065] one or more DNA construct(s) of 200 to 1000 bp, preferably of 300 to 900 bp, each comprising a fragment of a cDNA of a target gene selected among OSD1, SPO11-1, SPO11-2, PRD1, PAIR1, and REC8, or of its complementary, or having at least 95% identity, and by order of increasing preference, at least 96%, 97%, 98%, or 99% identity with said fragment, said DNA construct(s) being placed under transcriptional control of said promoter.
[0066] According to a preferred embodiment of the invention, an expression cassette for hpRNA comprises:
[0067] a promoter functional in a plant cell,
[0068] one or more hairpin DNA construct(s) capable, when transcribed, of forming a hairpin RNA targeting a gene selected among OSD1, SPO11-1, SPO11-2, PRD1, PAIR1, and REC8;
[0069] said DNA construct(s) being placed under transcriptional control of said promoter.
[0070] Generally, said hairpin DNA construct comprises: i) a first DNA sequence of 200 to 1000 bp, preferably of 300 to 900 bp, consisting of a fragment of a cDNA of the target gene, or having at least 95% identity, and by order of increasing preference, at least 96%, 97%, 98%, or 99% identity with said fragment; ii) a second DNA sequence that is the complementary of said first DNA, said first and second sequences being in opposite orientations and ii) a spacer sequence separating said first and second sequence, such that these first and second DNA sequences are capable, when transcribed, of forming a single double-stranded RNA molecule. The spacer can be a random fragment of DNA. However, preferably, one will use an intron which is spliceable by the target plant cell. Its size is generally 400 to 2000 nucleotides in length.
[0071] According to another preferred embodiment of the invention, an expression cassette for an amiRNA comprises:
[0072] a promoter functional in a plant cell,
[0073] one or more DNA construct(s) capable, when transcribed, of forming an amiRNA targeting a gene selected among OSD1, SPO11-1, SPO11-2, PRD1, PAIR1, and REC8;
[0074] said DNA construct(s) being placed under transcriptional control of said promoter.
[0075] Advantageously, an expression cassette of the invention comprises a DNA construct targeting the OSD1 gene. According to a particularly preferred embodiment it comprises: a DNA construct targeting the OSD1 gene, a DNA construct targeting a gene selected among, SPO11-1, SPO11-2, PRD1, and PAIR1, and a DNA construct targeting REC8.
[0076] A large choice of promoters suitable for expression of heterologous genes in plants is available in the art.
[0077] They can be obtained for instance from plants, plant viruses, or bacteria such as Agrobacterium. They include constitutive promoters, i.e. promoters which are active in most tissues and cells and under most environmental conditions, as well as tissue-specific or cell-specific promoters which are active only or mainly in certain tissues or certain cell types, and inducible promoters that are activated by physical or chemical stimuli, such as those resulting from nematode infection.
[0078] Non-limitative examples of constitutive promoters that are commonly used in plant cells are the cauliflower mosaic virus (CaMV) 35S promoter, the Nos promoter, the rubisco promoter, the Cassava vein Mosaic Virus (CsVMV) promoter.
[0079] Organ or tissue specific promoters that can be used in the present invention include in particular promoters able to confer meiosis-associated expression, such as the DMC1 promoter (KLIMYUK & JONES, Plant J, 11, 1-14, 1997); one can also use any of the the endogenous promoters of the genes OSD1, SPO11-1, SPO11-2, PRD1, PAIR1, or REC8.
[0080] The DNA constructs of the invention generally also include a transcriptional terminator (for instance the 35S transcriptional terminator, or the nopaline synthase (Nos) transcriptional terminator).
[0081] The invention also includes recombinant vectors containing a chimeric DNA construct of the invention. Classically, said recombinant vectors also include one or more marker genes, which allow for selection of transformed hosts.
[0082] The selection of suitable vectors and the methods for inserting DNA constructs therein are well known to persons of ordinary skill in the art. The choice of the vector depends on the intended host and on the intended method of transformation of said host. A variety of methods for genetic transformation of plant cells or plants are available in the art for many plant species, dicotyledons or monocotyledons. By way of non-limitative examples, one can mention virus mediated transformation, transformation by microinjection, by electroporation, microprojectile mediated transformation, Agrobacterium mediated transformation, and the like.
[0083] The invention also provides a host cell comprising a recombinant DNA construct of the invention. Said host cell can be a prokaryotic cell, for instance an Agrobacterium cell, or a eukaryotic cell, for instance a plant cell genetically transformed by a DNA construct of the invention. The construct may be transiently expressed; it can also be incorporated in a stable extrachromosomal replicon, or integrated in the chromosome.
[0084] According to a preferred embodiment of the method of the invention for providing a plant able to produce SDR 2n gametes, said plant is a transgenic plant, and said method comprises:
[0085] a) transforming at least one plant cell with a vector containing a DNA construct of the invention targeting the OSD1 gene;
[0086] b) cultivating said transformed plant cell in order to regenerate a plant having in its genome a transgene containing said DNA construct.
[0087] According to a preferred embodiment of the method of the invention for obtaining a plant able to produce apomeiotic gametes, said plant is a transgenic plant, and said method comprises:
[0088] a) transforming at least one plant cell with a vector containing a DNA construct of the invention targeting the OSD1 gene, a vector containing a DNA construct of the invention targeting a gene selected among SPO11-1, SPO11-2, PRD1, and PAIR1, and a vector containing a DNA construct of the invention targeting the REC8 gene;
[0089] b) cultivating said transformed plant cell in order to regenerate a plant having in its genome transgenes containing said DNA constructs.
[0090] According to another preferred embodiment of the method of the invention for obtaining a plant able to produce apomeiotic gametes, said plant is a transgenic plant, and said method comprises:
[0091] a) transforming at least one plant cell with a vector containing a DNA construct of the invention targeting the OSD1 gene, a DNA construct of the invention targeting a gene selected among SPO11-1, SPO11-2, PRD1, and PAIR1, and a vector containing a DNA construct of the invention targeting the REC8 gene;
[0092] b) cultivating said transformed plant cell in order to regenerate a plant having in its genome a transgene containing said DNA constructs.
[0093] The invention also encompasses plants able to produce SDR 2n gametes or apomeiotic gametes, obtainable by the methods of the invention.
[0094] This includes in particular plants comprising:
[0095] a mutation within the OSD1 gene, wherein the OSD1 protein is inhibited as a result of this mutation ; and
[0096] a mutation within a gene selected among SPO11-1, SPO11-2, PRD1, or PAIR1 gene, wherein the SPO11-1, SPO11-2, PRD1, or PAIR1 protein encoded by said gene is inhibited as a result of this mutation ; and
[0097] a mutation within the REC8 gene, wherein the Rec8 protein is inhibited as a result of this mutation.
[0098] This also includes plants genetically transformed by one or more DNA construct(s) of the invention. Preferably, said plants are transgenic plants, wherein said construct is contained in a transgene integrated in the plant genome, so that it is passed onto successive plant generations.
[0099] The expression of a chimeric DNA construct targeting the OSD1 gene, resulting in a down regulation of the OSD1 protein, provides to said transgenic plant the ability to produce 2n SDR gametes. The co-expression of a chimeric DNA construct targeting the OSD1 gene, a chimeric DNA construct targeting a gene selected among SPO11-1, SPO11-2, PRD1, and PAIR1, and a chimeric DNA construct targeting the REC8 gene, results in a down regulation of the proteins encoded by these three genes and provides to said transgenic plant the ability to produce apomeiotic gametes.
[0100] The invention also encompasses a method for producing SDR 2n gametes, wherein said method comprises cultivating a plant obtainable by a method of the invention and recovering the gametes produced by said plant. Preferably said gametes comprises at least 10%, more preferably at least 20%, and by order of increasing preference, at least 30%, 40%, 50%, 60% , 70%, 80%, or 90% of viable 2n gametes.
[0101] The invention also encompasses a method for producing apomeiotic gametes, wherein said method comprises cultivating a plant obtainable by a method of the invention and recovering the gametes produced by said plant. Preferably said gametes comprises at least 10%, more preferably at least 20%, and by order of increasing preference, at least 30%, 40%, 50%, or 60%, 70%, 80%, or 90% of viable apomeiotic gametes.
[0102] The present invention applies to a broad range of monocot- or dicotyledon plants of agronomical interest. By way of non-limitative examples, one can mention potato, rice, wheat, maize, tomato, cucumbers, alfalfa, sugar cane, sweet potato, manioc, clover, soybean, ray-grass, banana, melon, watermelon, cotton or ornamental plants such as roses, lilies, tulips, and narcissus.
[0103] Foregoing and other objects and advantages of the invention will become more apparent from the following detailed description and accompanying drawings. It is to be understood however that this foregoing detailed description is exemplary only and is not restrictive of the invention.
EXAMPLES
Experimental Procedures
Plant Material and Growth Conditions.
[0104] Arabidopsis plants were cultivated as described in VIGNARD et al., (PLoS Genet, 3, 1894-906, 2007). For germination assays and cytometry experiments Arabidopsis were cultivated in vitro on Arabidopsis medium (ESTELLE & SOMERVILLE, Mol. Gen. Genet., 206, 200-06, 1987) at 21.degree. C. with a 16 h day/8 h night photoperiod and 70% hygrometry.
Genetic Analysis.
[0105] Plants were genotyped by PCR (30 cycles of 30 s at 94.degree. C., 30 s at 56.degree. C. and 1 min at 72.degree. C.) using two primer pairs. For each genotype the primer pair is shown in Table I and the primer pair specific to the insertion is shown in Table II.
TABLE-US-00001 TABLE I Primers for Wild-type allele osd1-1 pst15307U (5'CGTCACTCTC CCCAAGAAAG 3') (SEQ ID NO: 7) pst15307L (5'GGCTAAGCAA GCCTGCTATG 3') (SEQ ID NO: 8) osd1-2 GT21481U (5'CCGGTGTTCT TGTGACTCG 3') (SEQ ID NO: 9) GT21481L (5'GCAGATTCCTA ATTCAGCTC 3') (SEQ ID NO: 10) Atspo11-1-3 N646172U (5' AATCGGTGAGT CAGGTTTCAG 3') (SEQ ID NO: 11) N646172L (5' CCATGGATGA AAGCGATTTAG 3') (SEQ ID NO: 12) Atrec8-3 N836037U (5'CTCATATTCAC GGTGCTCCC 3') (SEQ ID NO: 13) N836037L (5'GGGGGAAAAGA GAAAGGTTC 3') (SEQ ID NO: 14)
TABLE-US-00002 TABLE II Primers for mutant allele Primers for mutant allele osd1-1 pst15307L Ds5-2a (5'TCCGTTCCG TTTTCGTTTTTT AC3') (SEQ ID NO: 15) osd1-2 GT21481U Ds3-4 (5'CCGTCCCGC AAGTTAAATATG3') (SEQ ID NO: 16) Atspo11-1-3 N646172L LbSaIk2 (5' GCTTTCTTCCC TTCCTTTCTC 3') (SEQ ID NO: 17) Atrec8-3 N836137L LB3saiI (5'TAGCATCTGAAT TTCATAACCAATCTCG ATACAC3') (SEQ ID NO: 18)
[0106] Genetic markers used to genotype the osd1-1(No-0)/osd1-2(Ler).times.Col-0 F1 population and osd1-1(No-0)/spo11-1(Col-0)/rec8(Col-0) triple mutant.times.Ler F1 population are listed in Table III. The PCR conditions were 40 cycles of 30 s at 94.degree. C., 30 s at Tm and 30 s at 72.degree. C.
TABLE-US-00003 TABLE III Position Primer 1 Primer 2 marker Chrom. pb (SEQ ID NO:) (SEQ ID NO:) Msat1-13 1 25827433 CAACCACC GTCAAACCAGT AGGCTC(19) TCAATCA(20) F5i14 1 24374008 CTGCCTGA GGCATCACAGT AATTGTCG TCTGATTCC AAAC(21) (22) Msat2-18 2 2799644 TAGTCTCTT AGCCTCTCCAA TTGGTGCGC GCTTAGGTCT ATA(23) (24) Msat2-21 2 11461020 ATTTTTAGC AGGTCAAGTGA CCAATCACG AAGGGTAAGG TTT(25) (26) Msat2-9 2 18152580 TAAAAGAGT GTTGTTGTT CCCTCGTAA GTGGCATT AG(27) (28) CapsK4_ 4 10354800 ACCCATTTG GAGCAGTTTCC 10355 GTGATGCTA ACTTTGTCC AC(29) (30) Msat4-18 4 11966304 TGTAAATAT CTGAAACAAAT CGGCTTCTA CGCATTA AG(31) (32) Nga151 5 4669932 GTTTTGGGA CAGTCTAAAAGC AGTTTTGCT GAGAGTATGATG GG(33) (34)
[0107] These markers were amplified (40 cycles of 30 s at 94.degree. C., 30 s at 58.degree. C. and 30 s at 72.degree. C.) with the indicated primers and observed after migration on 3% agarose gel.
[0108] CAPS K4 10355 was observed after Eco47III/HpaII double digestion. The two primer pairs specific for the osd1-1 and osd1-2 insertion borders were used as a marker on chromosome 3.
Cytology and Flow Cytometry:
[0109] Final meiotic products were observed as described in AZUMI et al., (Embo J, 21, 3081-95., 2002) and viewed with a conventional light microscope with a 40.times. dry objective. Chromosomes spreads and observations were carried out using the technique described in MERCIER et al., (Biochimie, 83, 1023-28, 2001). The DNA fluorescence of spermatic pollen nuclei was quantified using open LAB 4.0.4 software. For each nucleus the surrounding background was calculated and subtracted from the global fluorescence of the nucleus. Meiotic spindles were observed according to the protocol described in MERCIER et al., (Genes Dev, 15, 1859-71, 2001) except that the DNA was counter-stained with DAPI. Observations were made using an SP2 Leica confocal microscope. Images were acquired with a 63.times. water objective in xyz and 3D reconstructions were made using Leica software. Projections are shown. Cells were imaged at excitation 488 nm and 405 nm with AlexaFluor488 and DAPI respectively. Arabidopsis genome sizes were measured as described in MARIE & BROWN, (Biol Cell, 78, 41-51, 1993) using tomato Lycopersicon esculentum cv "Montfavet" as the standard. (2 C=1.99 pg, % GC=40.0%).
Example 1: Production of Diploid Gametes By osd1 Mutants
[0110] As a part of an expression profiling screen for meiotic genes, using the Expression Angler tool(TOUFIGHI et al., Plant J, 43, 153-63, 2005) with the AtGenExpress tissue set (SCHMID et al., Nat Genet, 37, 501-6, 2005), At3g57860 was selected as a good candidate due to its co-regulation with several known meiotic genes. At3g57860 corresponds to the UVI4-Like gene (UVI4-L) which was briefly described in a study of its paralogue, the UVI4 gene (HASE et al., Plant J, 46, 317-26, 2006). Due to its role in meiosis (see below) we renamed the At3g57860 gene OSD1, for omission of second division. The OSD1 and UVI4 proteins are conserved throughout the plant kingdom but do not contain any obvious conserved known functional domains. No homologues were identified outside the plant kingdom.
[0111] We investigated the role of the OSD1 gene by isolating and characterizing two mutants. The osd1-1 (pst15307) and the osd1-2 (GT21481) Ds insertional mutants are in the Nooseen (No-0) and Landsberg (Ler) backgrounds, respectively, and in both cases the insertion is in the second exon of the OSD1 gene.
[0112] The intron/exon structure of the OSD1 gene and the location of the two different Ds insertions are shown in FIG. 2. The OSD1 gene contains 3 exons and 2 introns and encodes a protein of 243 amino acids. The positions of the two Ds insertions are indicated by triangles.
[0113] FIG. 3 represents meiosis in wild-type plants and FIG. 4 represents meiosis in osd1 mutants.
[0114] Legend of FIG. 3: (A) Pachytene. Homologous chromosomes are fully synapsed. (B) Diakinesis. Five pairs of homologous chromosomes (bivalent), linked by chiasmata, are observed. (C) Metaphase I. The five bivalent are aligned on the metaphase plate. (D) Anaphase I. The homologous chromosomes are separated. (E) Telophase I. (F) Metaphase II. The pairs of sister chromatids align on the metaphase plates. (G) Anaphase II. The sister chromatids are separated. (H and I) Telophase II. Four haploid spores are formed (tetrad). Scale bar=10 .mu.m.
[0115] Legend of FIG. 4: (A and B) Male meiotic products stained with toluidine blue. (A) A wild type tetrad. (B) A dyad in the osd1-1 mutant. (C to D) Male meiosis in osd1 is indistinguishable from wild type until telophase I (compare to FIG. 3), but no figures characteristic of a second division were observed. (C) pachytene. (D) diakinesis. (E) metaphase I. (F) Anaphase I. (G) Telophase I. (H) Metaphase I of female meiosis in osd1.
[0116] In both independent osd1 mutants the products of male meiosis were dyads (osd1-1: 714/714 osd1-2: 334/334) instead of tetrads (FIGS. 4A and B). Complementation tests between osd1-1 and osd1-2 confirmed that these mutations are allelic (osd1-1/osd1-2: 369 dyads/369), and thus demonstrated that the observed dyads are due to disruption of the OSD1 gene. Osd1 mutants did not show any somatic developmental defects, male and female gametophyte lethality or reduced fertility (wild type 38.+-.11 seeds/fruit, osd1 35.+-.6).
[0117] Next, we measured ploidy levels among the offspring of diploid osd1 mutants. Among selfed progeny, tetraploids (84%) and triploids (16%), but no diploid plants were found (osd1-1: n=56; osd1-2: n=24). When mutant pollen was used to fertilize a wild type plant, all the resulting progeny were triploid (osd1-1: n=75). When mutant ovules were fertilized with wild type pollen grains we isolated 12% diploid and 88% triploid plants (n=25). This demonstrated that the osd1 mutants produce high levels of male (100%) and female (.about.85%) diploid spores, which result in functional gametes.
[0118] To unravel the mechanisms leading to dyad production in osd1, we investigated chromosome behavior during meiosis. Both male and female meiosis I were indistinguishable from wild type (compare FIG. 4 with FIG. 3). Notably, chiasmata, the cytological manifestation of crossovers, and bivalents were observed. However, we were unable to find any meiosis II figures (among>500 male meiocytes from prophase to spore formation), strongly suggesting that dyad production is due to an absence of the second meiotic division. If this second division does not take place then any heterozygosis at centromeres will be lost in the diploid gametes because of sister chromatids co-segregation and homologous separation during the first division. Because of recombination, any loci which are not linked to centromeres will segregate. We tested our assumption by taking advantage of the two different genetic backgrounds of the osd1-1 (No-0) and osd1-2 mutants (Ler). F1 plants bearing the two mutations--mutant for osd1 and heterozygous for any No-0/Ler polymorphisms--were crossed as male or female to a third genetic background, Columbia (Col-0). Karyotyping and genotyping of the obtained plants for trimorphic molecular markers provided direct information on the genetic make-up of pollen grains and female gametophytes produced by the mutant. All the diploid gametes tested had the predicted genetic characteristics. They were systematically homozygous at centromeres and segregating--because of recombination--at other loci (n=48 for male diploid gametes and n=41 for female diploid gametes). These results confirmed that the absence of a second meiotic division is indeed the cause of 2n gametes production in osd1. This mechanism also implies that unbalanced chromosome segregation at meiosis I would give rise to unbalanced dyads in osd1; this was confirmed by analyzing a double Atspo11-1/osd1-1 mutant (data not shown).
[0119] Due to an absence of the second meiotic division, osd1 mutants produce high frequencies of viable diploid male and female gametophytes, which generate, after fecundation, viable tetraploid plants. However, this phenomenon differs from apomeiosis in that the produced gametes are genetically different from the mother plant.
Example 2: Production of Apomeiotic Gametes by Triple osd1/Atrec8/Atspo11-1 Mutants
[0120] In double Atspo 11-1/Atrec8 mutants the first meiotic division is replaced by a mitotic-like division, followed by an unbalanced second division which leads to unbalanced spores and sterility(CHELYSHEVA et al., J Cell Sci, 118, 4621-32, 2005).
[0121] We generated osd1/Atrec8/Atspo11-1 mutants. Plants heterozygous for both Atspo11-1 and Atrec8 mutations were obtained by crossing plants heterozygous for each mutation, and were crossed by a plant heterozygous for osd1. Triple heterozygous plants identified were self-fertilized and plants homozygous for the three mutations were analyzed.
[0122] Observation of chromosome behavior during male and female meiosis of these mutants is shown in FIG. 5.
[0123] Legend of FIG. 5: (A) Male metaphase I (B) Male anaphase I. The vignette shows a dyad in MiMe. (C) Female metaphase I. (D) Female anaphase I. Scale bar=10 .mu.m.
[0124] These observations revealed a mitotic-like division: 10 univalents aligned on the metaphase plate and sister chromatids separated at anaphase (FIG. 5).
[0125] The Atspo11-1 and Atrec8 mutations lead to a mitotic-like first meiotic division and the osd1 mutation prevents the second meiotic division from taking place. This results in replacement of meiosis by a mitotic-like division, and in apomeiosis.
[0126] We called this genotype MiMe for "mitosis instead of meiosis". MiMe plants generate dyads (408/408) and are fertile (25.+-.6 seeds per fruit). The osd1 mutation therefore suppressed the sterility phenotype of the Atspo11-1/Atrec8 double mutant.
[0127] The selfed progeny of MiMe plants were systematically tetraploid (n=24) and backcrosses between diploid MiMe plants and wild type plants generated triploid plants regardless of whether male (n=24) or female (n=67) MiMe gametes were used, showing that this mitotic-like division gives rise to functional diploid gametes. All the gametes (male and female), tested similarly as described above, systematically retained the mother plant heterozygosity for every genetic marker tested and were thus genetically identical to the mother plant. These results confirm that MiMe plants undergo a mitotic-like division instead of a normal meiotic division, without affecting subsequent sexual processes.
[0128] When meiosis is replaced by mitosis ploidy is expected to double with each generation. This was observed in MiMe plants, as shown in FIG. 6.
[0129] Legend of FIG. 6: Left column: mitotic metaphase, scale bar=10 .mu.m. Right columns: the corresponding four weeks old plants, (scale bar=2 cm) and flowers (scale bar=1 mm).
[0130] In subsequent generations, we obtained tetraploid (4N, 20 chromosomes, n=26) and octoploid (8N, 40 chromosomes, n=33).
Example 3: Identification of a Rice Ortholog of the Arabidopsis OSD1 Gene
[0131] The Oriza sativa genome contains two OSD1/UVI4 homologue candidates (Os02g37850 and Os04g39670). We isolated two T-DNA insertion mutants in one of this putative homologue (Os02g37850). The two lines, AMBA12 and AMQF10 were genotyped by PCR to select homozygotes. In both lines we observed spontaneous tetraploids plants among the offspring of diploid mutant plants, suggestive of the production of functional male and female 2n gametes (AMBA 12: 100% of tetraploid, n=30; AMQF10 37% of tetraploids, n=27). We then studied the meiotic products in AMB12 mutants (n>400) and observed the production of 100% of dyads instead of tetrads, as illustrated by FIG. 7.
[0132] Legend of FIG. 7: A: Tetrad of spores in wild type; B: Dyad of spores in AMB12.
[0133] This phenotype is identical to the Arabidopsis osd1 mutant. To unravel the mechanisms leading to dyad production in AMBA12 homozygote mutants, we investigated chromosome behavior during meiosis. Meiosis I was indistinguishable from wild type. Notably, chiasmata, the cytological manifestation of crossovers, and bivalents were observed. However, we were unable to find any meiosis II figures, strongly suggesting that 2N spores production is due to an absence of the second meiotic division, like in Arabidopsis osd1. Altogether, these results show that Os02g37850 is the functional homologue of Arabidopsis OSD1 and therefore called it OsOSD1. OSD1 and OsOSD1 proteins have 23.6% identity and 35% similarity on an alignment that covers the whole length of the sequences (EMBOSS pairwise alignment Needle tool).
Sequence CWU
1
1
351243PRTArabidopsis thaliana 1Met Pro Glu Ala Arg Asp Arg Thr Glu Arg Pro
Val Asp Tyr Ser Thr1 5 10
15Ile Phe Ala Asn Arg Arg Arg His Gly Ile Leu Leu Asp Glu Pro Asp
20 25 30Ser Arg Leu Ser Leu Ile Glu
Ser Pro Val Asn Pro Asp Ile Gly Ser 35 40
45Ile Gly Gly Thr Gly Gly Leu Val Arg Gly Asn Phe Thr Thr Trp
Arg 50 55 60Pro Gly Asn Gly Arg Gly
Gly His Thr Pro Phe Arg Leu Pro Gln Gly65 70
75 80Arg Glu Asn Met Pro Ile Val Thr Ala Arg Arg
Gly Arg Gly Gly Gly 85 90
95Leu Leu Pro Ser Trp Tyr Pro Arg Thr Pro Leu Arg Asp Ile Thr His
100 105 110Ile Val Arg Ala Ile Glu
Arg Arg Arg Gly Ala Gly Thr Gly Gly Asp 115 120
125Asp Gly Arg Val Ile Glu Ile Pro Thr His Arg Gln Val Gly
Val Leu 130 135 140Glu Ser Pro Val Pro
Leu Ser Gly Glu His Lys Cys Ser Met Val Thr145 150
155 160Pro Gly Pro Ser Val Gly Phe Lys Arg Ser
Cys Pro Pro Ser Thr Ala 165 170
175Lys Val Gln Lys Met Leu Leu Asp Ile Thr Lys Glu Ile Ala Glu Glu
180 185 190Glu Ala Gly Phe Ile
Thr Pro Glu Lys Lys Leu Leu Asn Ser Ile Asp 195
200 205Lys Val Glu Lys Ile Val Met Ala Glu Ile Gln Lys
Leu Lys Ser Thr 210 215 220Pro Gln Ala
Lys Arg Glu Glu Arg Glu Lys Arg Val Arg Thr Leu Met225
230 235 240Thr Met Arg2362PRTArabidopsis
thaliana 2Met Glu Gly Lys Phe Ala Ile Ser Glu Ser Thr Asn Leu Leu Gln
Arg1 5 10 15Ile Lys Asp
Phe Thr Gln Ser Val Val Val Asp Leu Ala Glu Gly Arg 20
25 30Ser Pro Lys Ile Ser Ile Asn Gln Phe Arg
Asn Tyr Cys Met Asn Pro 35 40
45Glu Ala Asp Cys Leu Cys Ser Ser Asp Lys Pro Lys Gly Gln Glu Ile 50
55 60Phe Thr Leu Lys Lys Glu Pro Gln Thr
Tyr Arg Ile Asp Met Leu Leu65 70 75
80Arg Val Leu Leu Ile Val Gln Gln Leu Leu Gln Glu Asn Arg
His Ala 85 90 95Ser Lys
Arg Asp Ile Tyr Tyr Met His Pro Ser Ala Phe Lys Ala Gln 100
105 110Ser Ile Val Asp Arg Ala Ile Gly Asp
Ile Cys Ile Leu Phe Gln Cys 115 120
125Ser Arg Tyr Asn Leu Asn Val Val Ser Val Gly Asn Gly Leu Val Met
130 135 140Gly Trp Leu Lys Phe Arg Glu
Ala Gly Arg Lys Phe Asp Cys Leu Asn145 150
155 160Ser Leu Asn Thr Ala Tyr Pro Val Pro Val Leu Val
Glu Glu Val Glu 165 170
175Asp Ile Val Ser Leu Ala Glu Tyr Ile Leu Val Val Glu Lys Glu Thr
180 185 190Val Phe Gln Arg Leu Ala
Asn Asp Met Phe Cys Lys Thr Asn Arg Cys 195 200
205Ile Val Ile Thr Gly Arg Gly Tyr Pro Asp Val Ser Thr Arg
Arg Phe 210 215 220Leu Arg Leu Leu Met
Glu Lys Leu His Leu Pro Val His Cys Leu Val225 230
235 240Asp Cys Asp Pro Tyr Gly Phe Glu Ile Leu
Ala Thr Tyr Arg Phe Gly 245 250
255Ser Met Gln Met Ala Tyr Asp Ile Glu Ser Leu Arg Ala Pro Asp Met
260 265 270Lys Trp Leu Gly Ala
Phe Pro Ser Asp Ser Glu Val Tyr Ser Val Pro 275
280 285Lys Gln Cys Leu Leu Pro Leu Thr Glu Glu Asp Lys
Lys Arg Thr Glu 290 295 300Ala Met Leu
Leu Arg Cys Tyr Leu Lys Arg Glu Met Pro Gln Trp Arg305
310 315 320Leu Glu Leu Glu Thr Met Leu
Lys Arg Gly Val Lys Phe Glu Ile Glu 325
330 335Ala Leu Ser Val His Ser Leu Ser Phe Leu Ser Glu
Val Tyr Ile Pro 340 345 350Ser
Lys Ile Arg Arg Glu Val Ser Ser Pro 355
3603383PRTArabidopsis thaliana 3Met Glu Glu Ser Ser Gly Leu Ser Ser Met
Lys Phe Phe Ser Asp Gln1 5 10
15His Leu Ser Tyr Ala Asp Ile Leu Leu Pro His Glu Ala Arg Ala Arg
20 25 30Ile Glu Val Ser Val Leu
Asn Leu Leu Arg Ile Leu Asn Ser Pro Asp 35 40
45Pro Ala Ile Ser Asp Leu Ser Leu Ile Asn Arg Lys Arg Ser
Asn Ser 50 55 60Cys Ile Asn Lys Gly
Ile Leu Thr Asp Val Ser Tyr Ile Phe Leu Ser65 70
75 80Thr Ser Phe Thr Lys Ser Ser Leu Thr Asn
Ala Lys Thr Ala Lys Ala 85 90
95Phe Val Arg Val Trp Lys Val Met Glu Ile Cys Phe Gln Ile Leu Leu
100 105 110Gln Glu Lys Arg Val
Thr Gln Arg Glu Leu Phe Tyr Lys Leu Leu Cys 115
120 125Asp Ser Pro Asp Tyr Phe Ser Ser Gln Ile Glu Val
Asn Arg Ser Val 130 135 140Gln Asp Val
Val Ala Leu Leu Arg Cys Ser Arg Tyr Ser Leu Gly Ile145
150 155 160Met Ala Ser Ser Arg Gly Leu
Val Ala Gly Arg Leu Phe Leu Gln Glu 165
170 175Pro Gly Lys Glu Ala Val Asp Cys Ser Ala Cys Gly
Ser Ser Gly Phe 180 185 190Ala
Ile Thr Gly Asp Leu Asn Leu Leu Asp Asn Thr Ile Met Arg Thr 195
200 205Asp Ala Arg Tyr Ile Ile Ile Val Glu
Lys His Ala Ile Phe His Arg 210 215
220Leu Val Glu Asp Arg Val Phe Asn His Ile Pro Cys Val Phe Ile Thr225
230 235 240Ala Lys Gly Tyr
Pro Asp Ile Ala Thr Arg Phe Phe Leu His Arg Met 245
250 255Ser Thr Thr Phe Pro Asp Leu Pro Ile Leu
Val Leu Val Asp Trp Asn 260 265
270Pro Ala Gly Leu Ala Ile Leu Cys Thr Phe Lys Phe Gly Ser Ile Gly
275 280 285Met Gly Leu Glu Ala Tyr Arg
Tyr Ala Cys Asn Val Lys Trp Ile Gly 290 295
300Leu Arg Gly Asp Asp Leu Asn Leu Ile Pro Glu Glu Ser Leu Val
Pro305 310 315 320Leu Lys
Pro Lys Asp Ser Gln Ile Ala Lys Ser Leu Leu Ser Ser Lys
325 330 335Ile Leu Gln Glu Asn Tyr Ile
Glu Glu Leu Ser Leu Met Val Gln Thr 340 345
350Gly Lys Arg Ala Glu Ile Glu Ala Leu Tyr Cys His Gly Tyr
Asn Tyr 355 360 365Leu Gly Lys Tyr
Ile Ala Thr Lys Ile Val Gln Gly Lys Tyr Ile 370 375
38041330PRTArabidopsis thaliana 4Met Phe Phe Gln His Ser Gln
Leu Gln Asn Ser Asp His Leu Leu His1 5 10
15Glu Ser Met Ala Asp Ser Asn His Gln Ser Leu Ser Pro
Pro Cys Ala 20 25 30Asn Gly
His Arg Ser Thr Ile Ser Leu Arg Asp Asp Gln Gly Gly Thr 35
40 45Phe Cys Leu Ile Cys Phe Ser Asn Leu Val
Ser Asp Pro Arg Ile Pro 50 55 60Thr
Val His Val Ser Tyr Ala Leu His Gln Leu Ser Ile Ala Ile Ser65
70 75 80Glu Pro Ile Phe Leu Arg
Thr Leu Leu Ser Ser His Ile His Phe Leu 85
90 95Val Ser Pro Leu Val His Ala Leu Ser Ser Ile Asp
Asp Ala Pro Ile 100 105 110Ala
Ile Gln Ile Met Asp Met Ile Ser Leu Leu Cys Ser Val Glu Glu 115
120 125Ser Ser Ile Gly Glu Asp Phe Val Glu
Arg Ile Ser Asp Gln Leu Ser 130 135
140Ser Gly Ala Leu Gly Trp Ser Arg Arg Gln Leu His Met Leu His Cys145
150 155 160Phe Gly Val Leu
Met Ser Cys Glu Asn Ile Asp Ile Asn Ser His Ile 165
170 175Arg Asp Lys Glu Ala Leu Val Cys Gln Leu
Val Glu Gly Leu Gln Leu 180 185
190Pro Ser Glu Glu Ile Arg Gly Glu Ile Leu Phe Ala Leu Tyr Lys Phe
195 200 205Ser Ala Leu Gln Phe Thr Glu
Gln Asn Val Asp Gly Ile Glu Val Leu 210 215
220Ser Leu Leu Cys Pro Lys Leu Leu Cys Leu Ser Leu Glu Ala Leu
Ala225 230 235 240Lys Thr
Gln Arg Asp Asp Val Arg Leu Asn Cys Val Ala Leu Leu Thr
245 250 255Ile Leu Ala Gln Gln Gly Leu
Leu Ala Asn Ser His Ser Asn Ser Ala 260 265
270Ser Ser Met Ser Leu Asp Glu Val Asp Asp Asp Pro Met Gln
Thr Ala 275 280 285Glu Asn Val Ala
Ala Arg Pro Cys Leu Asn Val Leu Phe Ala Glu Ala 290
295 300Ile Lys Gly Pro Leu Leu Ser Thr Asp Ser Glu Val
Gln Ile Lys Thr305 310 315
320Leu Asp Leu Ile Phe His Tyr Ile Ser Gln Glu Ser Thr Pro Ser Lys
325 330 335Gln Ile Gln Val Met
Val Glu Glu Asn Val Ala Asp Tyr Ile Phe Glu 340
345 350Ile Leu Arg Leu Ser Glu Cys Lys Asp Gln Val Val
Asn Ser Cys Leu 355 360 365Arg Val
Leu Asp Leu Phe Ser Leu Ala Glu His Ser Phe Arg Lys Arg 370
375 380Leu Val Ile Gly Phe Pro Ser Val Ile Arg Val
Leu His Tyr Val Gly385 390 395
400Glu Val Pro Cys His Pro Phe Gln Ile Gln Thr Leu Lys Leu Ile Ser
405 410 415Ser Cys Ile Ser
Asp Phe Pro Gly Ile Ala Ser Ser Ser Gln Val Gln 420
425 430Glu Ile Ala Leu Val Leu Lys Lys Met Leu Glu
Arg Tyr Tyr Ser Gln 435 440 445Glu
Met Gly Leu Phe Pro Asp Ala Phe Ala Ile Ile Cys Ser Val Phe 450
455 460Val Ser Leu Met Lys Thr Pro Ser Phe Gly
Glu Thr Ala Asp Val Leu465 470 475
480Thr Ser Leu Gln Glu Ser Leu Arg His Ser Ile Leu Ala Ser Leu
Ser 485 490 495Leu Pro Glu
Lys Asp Ser Thr Gln Ile Leu His Ala Val Tyr Leu Leu 500
505 510Asn Glu Ile Tyr Val Tyr Cys Thr Ala Ser
Thr Ser Ile Asn Met Thr 515 520
525Ser Cys Ile Glu Leu Arg His Cys Val Ile Asp Val Cys Thr Ser His 530
535 540Leu Leu Pro Trp Phe Leu Ser Asp
Val Asn Glu Val Asn Glu Glu Ala545 550
555 560Thr Leu Gly Ile Met Glu Thr Phe His Ser Ile Leu
Leu Gln Asn Ser 565 570
575Asp Ile Gln Ala Lys Glu Phe Ala Glu Leu Leu Val Ser Ala Asp Trp
580 585 590Phe Ser Phe Ser Phe Gly
Cys Leu Gly Asn Phe Cys Thr Asp Asn Met 595 600
605Lys Gln Arg Ile Tyr Leu Met Leu Ser Ser Leu Val Asp Ile
Leu Leu 610 615 620Glu Gln Lys Thr Gly
Ser His Ile Arg Asp Ala Leu His Cys Leu Pro625 630
635 640Ser Asp Pro Gln Asp Leu Leu Phe Leu Leu
Gly Gln Ala Ser Ser Asn 645 650
655Asn Gln Glu Leu Ala Ser Cys Gln Ser Ala Ala Leu Leu Ile Phe His
660 665 670Thr Ser Ser Ile Tyr
Asn Asp Arg Leu Ala Asp Asp Lys Leu Val Leu 675
680 685Ala Ser Leu Glu Gln Tyr Ile Ile Leu Asn Lys Thr
Ser Leu Ile Cys 690 695 700Ala Ile Ser
Asp Ser Pro Ala Leu Leu Asn Leu Val Asn Leu Tyr Gly705
710 715 720Leu Cys Arg Ser Leu Gln Asn
Glu Arg Tyr Gln Ile Ser Tyr Ser Leu 725
730 735Glu Ala Glu Arg Ile Ile Phe His Leu Leu Asn Glu
Tyr Glu Trp Asp 740 745 750Leu
Gly Ser Ile Asn Ile His Leu Glu Ser Leu Lys Trp Leu Phe Gln 755
760 765Gln Glu Ser Ile Ser Lys Ser Leu Ile
Tyr Gln Ile Gln Lys Ile Ser 770 775
780Arg Asn Asn Leu Ile Gly Asn Glu Val His Asn Val Tyr Gly Asp Gly785
790 795 800Arg Gln Arg Ser
Leu Thr Tyr Trp Phe Ala Lys Leu Ile Ser Glu Gly 805
810 815Asp Asn Tyr Ala Ala Thr Leu Leu Val Asn
Leu Leu Thr Gln Leu Ala 820 825
830Glu Lys Glu Glu Gln Glu Asn Asp Val Thr Ser Ile Leu Asn Leu Met
835 840 845Asn Thr Ile Val Ser Ile Phe
Pro Thr Ala Ser Asn Asn Leu Ser Met 850 855
860Asn Gly Ile Gly Ser Val Val His Arg Leu Val Ser Gly Phe Ser
Asn865 870 875 880Ser Ser
Leu Gly Thr Ser Phe Lys Thr Leu Leu Leu Leu Val Phe Asn
885 890 895Ile Leu Thr Ser Val Gln Pro
Ala Val Leu Met Ile Asp Glu Ser Trp 900 905
910Tyr Ala Val Ser Ile Lys Leu Leu Asn Phe Leu Ser Leu Arg
Asp Thr 915 920 925Ala Ile Lys Gln
Asn His Glu Asp Met Val Val Ile Gly Ile Leu Ser 930
935 940Leu Val Leu Tyr His Ser Ser Asp Gly Ala Leu Val
Glu Ala Ser Arg945 950 955
960Asn Ile Val Ser Asn Ser Tyr Leu Val Ser Ala Ile Asn Thr Val Val
965 970 975Asp Val Ala Cys Ser
Lys Gly Pro Ala Leu Thr Gln Cys Gln Asp Glu 980
985 990Thr Asn Ile Gly Glu Ala Leu Ala Phe Thr Leu Leu
Leu Tyr Phe Phe 995 1000 1005Ser
Leu Arg Ser Leu Gln Ile Val Leu Ala Gly Ala Val Asp Trp 1010
1015 1020Gln Ala Phe Phe Gly Thr Ser Thr Ser
Leu Glu Thr Leu Pro Val 1025 1030
1035Val Cys Ile Tyr Cys His Asn Leu Cys Arg Leu Met His Phe Gly
1040 1045 1050Ala Pro Gln Ile Lys Leu
Ile Ala Ser Tyr Cys Leu Leu Glu Leu 1055 1060
1065Leu Thr Gly Leu Ser Glu Gln Val Asp Ile Lys Lys Glu Gln
Leu 1070 1075 1080Gln Cys Ser Ser Ser
Tyr Leu Lys Ser Met Lys Ala Val Leu Gly 1085 1090
1095Gly Leu Val Phe Cys Asp Asp Ile Arg Val Ala Thr Asn
Ser Ala 1100 1105 1110Leu Cys Leu Ser
Met Ile Leu Gly Trp Glu Asp Met Glu Gly Arg 1115
1120 1125Thr Glu Met Leu Lys Thr Ser Ser Trp Tyr Arg
Phe Ile Ala Glu 1130 1135 1140Glu Met
Ser Val Ser Leu Ala Leu Pro Cys Ser Ala Ser Ser Thr 1145
1150 1155Tyr Val Asn His His Lys Pro Ala Val Tyr
Leu Thr Val Ala Met 1160 1165 1170Leu
Arg Leu Lys Asn Lys Pro Val Trp Leu Arg Thr Val Phe Asp 1175
1180 1185Glu Ser Cys Ile Ser Ser Met Ile Gln
Asn Leu Asn Gly Ile Asn 1190 1195
1200Ile Ser Arg Glu Ile Val Ile Leu Phe Arg Glu Leu Met Gln Ala
1205 1210 1215Glu Leu Leu Asn Ser Gln
Gln Val Thr Lys Leu Asp Arg Ala Phe 1220 1225
1230Gln Glu Cys Arg Lys Gln Met His Arg Asn Gly Thr Arg Asp
Glu 1235 1240 1245Thr Val Glu Glu Gln
Val Gln Arg Lys Ile Pro Ser Ile His Asp 1250 1255
1260His Ser Glu Phe Cys Asn Tyr Leu Val His Leu Met Val
Ser Asn 1265 1270 1275Ser Phe Gly His
Pro Ser Glu Ser Glu Thr Tyr Thr Gln Lys Lys 1280
1285 1290Lys Gln Ile Leu Asp Glu Met Glu Gln Leu Ser
Glu Leu Ile Ser 1295 1300 1305Thr Arg
Glu Gly Arg Val Ser Pro Ile Gln Glu Glu Thr Arg Gln 1310
1315 1320Met Gln Thr Glu Arg Ile Val 1325
13305449PRTArabidopsis thaliana 5Met Lys Met Asn Ile Asn Lys Ala
Cys Asp Leu Lys Ser Ile Ser Val1 5 10
15Phe Pro Pro Asn Leu Arg Arg Ser Ala Glu Pro Gln Ala Ser
Gln Gln 20 25 30Leu Arg Ser
Gln Gln Ser Gln Gln Ser Phe Ser Gln Gly Pro Ser Ser 35
40 45Ser Gln Arg Gly Cys Gly Gly Phe Ser Gln Met
Thr Gln Ser Ser Ile 50 55 60Asp Glu
Leu Leu Ile Asn Asp Gln Arg Phe Ser Ser Gln Glu Arg Asp65
70 75 80Leu Ser Leu Lys Lys Val Ser
Ser Cys Leu Pro Pro Ile Asn His Lys 85 90
95Arg Glu Asp Ser Gln Leu Val Ala Ser Arg Ser Ser Ser
Gly Leu Ser 100 105 110Arg Arg
Trp Ser Ser Ala Ser Ile Gly Glu Ser Lys Ser Gln Ile Ser 115
120 125Glu Glu Leu Glu Gln Arg Phe Gly Met Met
Glu Thr Ser Leu Ser Arg 130 135 140Phe
Gly Met Met Leu Asp Ser Ile Gln Ser Asp Ile Met Gln Ala Asn145
150 155 160Arg Gly Thr Lys Glu Val
Phe Leu Glu Thr Glu Arg Ile Gln Gln Lys 165
170 175Leu Thr Leu Gln Asp Thr Ser Leu Gln Gln Leu Arg
Lys Glu Gln Ala 180 185 190Asp
Ser Lys Ala Ser Leu Asp Gly Gly Val Lys Phe Ile Leu Glu Glu 195
200 205Phe Ser Lys Asp Pro Asn Gln Glu Lys
Leu Gln Lys Ile Leu Gln Met 210 215
220Leu Thr Thr Ile Pro Glu Gln Val Glu Thr Ala Leu Gln Lys Ile Gln225
230 235 240Arg Glu Ile Cys
His Thr Phe Thr Arg Glu Ile Gln Val Leu Ala Ser 245
250 255Leu Arg Thr Pro Glu Pro Arg Val Arg Val
Pro Thr Ala Pro Gln Val 260 265
270Lys Ala Lys Glu Asn Leu Pro Glu Gln Arg Gly Gln Ala Ala Lys Val
275 280 285Leu Thr Ser Leu Lys Met Pro
Glu Pro Arg Val Gln Val Pro Ala Ala 290 295
300Pro Gln Ala Lys Glu Asn Phe Pro Glu Gln Arg Gly Pro Val Ala
Lys305 310 315 320Ser Asn
Ser Phe Cys Asn Thr Thr Leu Lys Thr Lys Gln Pro Gln Phe
325 330 335Pro Arg Asn Pro Asn Asp Ala
Ser Ala Arg Ala Val Lys Pro Tyr Leu 340 345
350Ser Pro Lys Ile Gln Val Gly Cys Trp Lys Thr Val Lys Pro
Glu Lys 355 360 365Ser Asn Phe Lys
Lys Arg Ala Thr Arg Lys Pro Val Lys Ser Glu Ser 370
375 380Thr Arg Thr Gln Phe Glu Gln Cys Ser Val Val Ile
Asp Ser Asp Glu385 390 395
400Glu Asp Ile Asp Gly Gly Phe Ser Cys Leu Ile Asn Glu Asn Thr Arg
405 410 415Gly Thr Asn Phe Glu
Trp Asp Ala Glu Lys Glu Thr Glu Arg Ile Leu 420
425 430Arg Thr Ala Arg Arg Thr Lys Arg Lys Phe Gly Asn
Pro Ile Ile Ile 435 440
445Asn6617PRTArabidopsis thaliana 6Met Phe Tyr Ser His Gln Leu Leu Ala
Arg Lys Ala Pro Leu Gly Gln1 5 10
15Ile Trp Met Ala Ala Thr Leu His Ala Lys Ile Asn Arg Lys Lys
Leu 20 25 30Asp Lys Leu Asp
Ile Ile Gln Ile Cys Glu Glu Ile Leu Asn Pro Ser 35
40 45Val Pro Met Ala Leu Arg Leu Ser Gly Ile Leu Met
Gly Gly Val Val 50 55 60Ile Val Tyr
Glu Arg Lys Val Lys Leu Leu Phe Asp Asp Val Asn Arg65 70
75 80Phe Leu Val Glu Ile Asn Gly Ala
Trp Arg Thr Lys Ser Val Pro Asp 85 90
95Pro Thr Leu Leu Pro Lys Gly Lys Thr His Ala Arg Lys Glu
Ala Val 100 105 110Thr Leu Pro
Glu Asn Glu Glu Ala Asp Phe Gly Asp Phe Glu Gln Thr 115
120 125Arg Asn Val Pro Lys Phe Gly Asn Tyr Met Asp
Phe Gln Gln Thr Phe 130 135 140Ile Ser
Met Arg Leu Asp Glu Ser His Val Asn Asn Asn Pro Glu Pro145
150 155 160Glu Asp Leu Gly Gln Gln Phe
His Gln Ala Asp Ala Glu Asn Ile Thr 165
170 175Leu Phe Glu Tyr His Gly Ser Phe Gln Thr Asn Asn
Glu Thr Tyr Asp 180 185 190Arg
Phe Glu Arg Phe Asp Ile Glu Gly Asp Asp Glu Thr Gln Met Asn 195
200 205Ser Asn Pro Arg Glu Gly Ala Glu Ile
Pro Thr Thr Leu Ile Pro Ser 210 215
220Pro Pro Arg His His Asp Ile Pro Glu Gly Val Asn Pro Thr Ser Pro225
230 235 240Gln Arg Gln Glu
Gln Gln Glu Asn Arg Arg Asp Gly Phe Ala Glu Gln 245
250 255Met Glu Glu Gln Asn Ile Pro Asp Lys Glu
Glu His Asp Arg Pro Gln 260 265
270Pro Ala Lys Lys Arg Ala Arg Lys Thr Ala Thr Ser Ala Met Asp Tyr
275 280 285Glu Gln Thr Ile Ile Ala Gly
His Val Tyr Gln Ser Trp Leu Gln Asp 290 295
300Thr Ser Asp Ile Leu Cys Arg Gly Glu Lys Arg Lys Val Arg Gly
Thr305 310 315 320Ile Arg
Pro Asp Met Glu Ser Phe Lys Arg Ala Asn Met Pro Pro Thr
325 330 335Gln Leu Phe Glu Lys Asp Ser
Ser Tyr Pro Pro Gln Leu Tyr Gln Leu 340 345
350Trp Ser Lys Asn Thr Gln Val Leu Gln Thr Ser Ser Ser Glu
Ser Arg 355 360 365His Pro Asp Leu
Arg Ala Glu Gln Ser Pro Gly Phe Val Gln Glu Arg 370
375 380Met His Asn His His Gln Thr Asp His His Glu Arg
Ser Asp Thr Ser385 390 395
400Ser Gln Asn Leu Asp Ser Pro Ala Glu Ile Leu Arg Thr Val Arg Thr
405 410 415Gly Lys Gly Ala Ser
Val Glu Ser Met Met Ala Gly Ser Arg Ala Ser 420
425 430Pro Glu Thr Ile Asn Arg Gln Ala Ala Asp Ile Asn
Val Thr Pro Phe 435 440 445Tyr Ser
Gly Asp Asp Val Arg Ser Met Pro Ser Thr Pro Ser Ala Arg 450
455 460Gly Ala Ala Ser Ile Asn Asn Ile Glu Ile Ser
Ser Lys Ser Arg Met465 470 475
480Pro Asn Arg Lys Arg Pro Asn Ser Ser Pro Arg Arg Gly Leu Glu Pro
485 490 495Val Ala Glu Glu
Arg Pro Trp Glu His Arg Glu Tyr Glu Phe Glu Phe 500
505 510Ser Met Leu Pro Glu Lys Arg Phe Thr Ala Asp
Lys Glu Ile Leu Phe 515 520 525Glu
Thr Ala Ser Thr Gln Thr Gln Lys Pro Val Cys Asn Gln Ser Asp 530
535 540Glu Met Ile Thr Asp Ser Ile Lys Ser His
Leu Lys Thr His Phe Glu545 550 555
560Thr Pro Gly Ala Pro Gln Val Glu Ser Leu Asn Lys Leu Ala Val
Gly 565 570 575Met Asp Arg
Asn Ala Ala Ala Lys Leu Phe Phe Gln Ser Cys Val Leu 580
585 590Ala Thr Arg Gly Val Ile Lys Val Asn Gln
Ala Glu Pro Tyr Gly Asp 595 600
605Ile Leu Ile Ala Arg Gly Pro Asn Met 610
615720DNAArtificialPCR primer 7cgtcactctc cccaagaaag
20820DNAArtificialPCR primer 8ggctaagcaa
gcctgctatg
20919DNAArtificialPCR primer 9ccggtgttct tgtgactcg
191020DNAArtificialPCR primer 10gcagattcct
aattcagctc
201121DNAArtificialPCR primer 11aatcggtgag tcaggtttca g
211221DNAArtificialPCR primer 12ccatggatga
aagcgattta g
211320DNAArtificialPCR primer 13ctcatattca cggtgctccc
201420DNAArtificialPCR primer 14gggggaaaag
agaaaggttc
201523DNAArtificialPCR primer 15tccgttccgt tttcgttttt tac
231621DNAArtificialPCR primer 16ccgtcccgca
agttaaatat g
211721DNAArtificialPCR primer 17gctttcttcc cttcctttct c
211834DNAArtificialPCR primer 18tagcatctga
atttcataac caatctcgat acac
341914DNAArtificialPCR primer 19caaccaccag gctc
142018DNAArtificialPCR primer 20gtcaaaccag
ttcaatca
182120DNAArtificialPCR primer 21ctgcctgaaa ttgtcgaaac
202220DNAArtificialPCR primer 22ggcatcacag
ttctgattcc
202321DNAArtificialPCR primer 23tagtctcttt tggtgcgcat a
212421DNAArtificialPCR primer 24agcctctcca
agcttaggtc t
212521DNAArtificialPCR primer 25atttttagcc caatcacgtt t
212621DNAArtificialPCR primer 26aggtcaagtg
aaagggtaag g
212720DNAArtificialPCR primer 27taaaagagtc cctcgtaaag
202817DNAArtificialPCR primer 28gttgttgttg
tggcatt
172920DNAArtificialPCR primer 29acccatttgg tgatgctaac
203020DNAArtificialPCR primer 30gagcagtttc
cactttgtcc
203120DNAArtificialPCR primer 31tgtaaatatc ggcttctaag
203218DNAArtificialPCR primer 32ctgaaacaaa
tcgcatta
183320DNAArtificialPCR primer 33gttttgggaa gttttgctgg
203424DNAArtificialPCR primer 34cagtctaaaa
gcgagagtat gatg
2435234PRTOryza sativa 35Met Pro Glu Val Arg Asn Ser Gly Gly Arg Ala Ala
Leu Ala Asp Pro1 5 10
15Ser Gly Gly Gly Phe Phe Ile Arg Arg Thr Thr Ser Pro Pro Gly Ala
20 25 30Val Ala Val Lys Pro Leu Ala
Arg Arg Ala Leu Pro Pro Thr Ser Asn 35 40
45Lys Glu Asn Val Pro Pro Ser Trp Ala Val Thr Val Arg Ala Thr
Pro 50 55 60Lys Arg Arg Ser Pro Leu
Pro Glu Trp Tyr Pro Arg Ser Pro Leu Arg65 70
75 80Asp Ile Thr Ser Val Val Lys Ala Val Glu Arg
Lys Ser Arg Leu Gly 85 90
95Asn Ala Ala Val Arg Gln Gln Ile Gln Leu Ser Glu Asp Ser Ser Arg
100 105 110Ser Val Asp Pro Ala Thr
Pro Val Gln Lys Glu Glu Gly Val Pro Gln 115 120
125Ser Thr Pro Thr Pro Pro Thr Gln Lys Ala Leu Asp Ala Ala
Ala Pro 130 135 140Cys Pro Gly Ser Thr
Gln Ala Val Ala Ser Thr Ser Thr Ala Tyr Leu145 150
155 160Ala Glu Gly Lys Pro Lys Ala Ser Ser Ser
Ser Pro Ser Asp Cys Ser 165 170
175Phe Gln Thr Pro Ser Arg Pro Asn Asp Pro Ala Leu Ala Asp Leu Met
180 185 190Glu Lys Glu Leu Ser
Ser Ser Ile Glu Gln Ile Glu Lys Met Val Arg 195
200 205Lys Asn Leu Lys Arg Ala Pro Lys Ala Ala Gln Pro
Ser Lys Val Thr 210 215 220Ile Gln Lys
Arg Thr Leu Leu Ser Met Arg225 230
User Contributions:
Comment about this patent or add new information about this topic: